2023-507529-41-00
已完成
1 期
MK-1084 Single and Multiple Dose Healthy Participant Study
概览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 27
- 试验地点
- 1
概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Julie Fiore
Scientific
Merck Sharp & Dohme LLC
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)NCT07266818Merck Sharp & Dohme LLC30
招募中
1 期
A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid TumorsNCT07274852Sichuan Baili Pharmaceutical Co., Ltd.22
尚未招募
不适用
QTc Assessment in a Single-Dose Study of Hydronidone CapsulesNCT07263152Beijing Continent Pharmaceutical Co, Ltd.48
Enrolling By Invitation
2 期
A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)NCT07266090Viatris Pharmaceuticals Co., Ltd.15
已完成
不适用
Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mgNCT07266766Humanis Saglık Anonim Sirketi40